Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Caro: Lifetime costs of complications resulting from type 2 diabetes in the US. (0.10 sec) 

Lifetime costs of complications resulting from type 2 diabetes in the US

- diabetesjournals.org
JJ Caro, AJ Ward, JA O'Brien - Diabetes Care, 2002 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—A cohort of 10,000 patients with diabetes was
simulated using a model based on existing epidemiological studies. Complication
rates were estimated for various stages of macrovascular disease, ...
Cited by 102 - Related articles - BL Direct - All 5 versions

Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment …


JJ Caro, WS Klittich, G Raggio, PL Kavanagh … - Clinical therapeutics, 2000 - Elsevier
We conducted an economic analysis based on glycemic-control data from a
randomized clinical trial comparing troglitazone with placebo, each added to
glyburide. A patient simulation model was used to translate these data to ...
Cited by 13 - Related articles - BL Direct - All 5 versions

Health and economic effects of adding nateglinide to metformin to achieve dual control of …


M Salas, A Ward, J Caro - Clinical therapeutics, 2002 - Elsevier
Methods: A pharmacoeconomic model was developed to simulate the long-term (30
years) complication rates (microvascular and macrovascular) of a cohort of
patients with type 2 diabetes mellitus. The model simulated each year of ...
Cited by 10 - Related articles - All 4 versions

Health and economic impact of combining metformin with nateglinide to achieve glycemic …


AJ Ward, M Salas, JJ Caro, D Owens - Cost Effectiveness and Resource Allocation, 2004 - biomedcentral.com
An existing model that simulates the long-term course of type 2 diabetes in
relation to glycosylated haemoglobin (HbA 1c ) and post-prandial glucose (PPG)
was used to compare the combination of nateglinide with metformin to ...
Cited by 3 - Related articles - Cached - All 12 versions

Direct medical costs of complications resulting from type 2 diabetes in the US

- diabetesjournals.org [PDF] 
JA O'Brien, LA Shomphe, PL Kavanagh, G … - Diabetes Care, 1998 - Am Diabetes Assoc
Ap p roximately 8 million Americans are known to have diabetes. Every year, on
average, 625,000 new cases of dia- betes are diagnosed, and more than 178,000
deaths result from the disease and its related complications (1,2). ...
Cited by 87 - Related articles - BL Direct - All 6 versions

Estimates of direct medical costs for microvascular and macrovascular complications …


JA O'Brien, AR Patrick, J Caro - Clinical therapeutics, 2003 - Elsevier
Background: Diabetes mellitus is a chronic condition that affects the health of
Americans and the US health care system on many levels. According to the
American Diabetes Association, 16 million Americans have diabetes mellitus. ...
Cited by 69 - Related articles - All 5 versions

[CITATION] Lifetime costs of complications resulting from type 2 diabetes in the US Diabetes Care 25: …


JJ Caro, AJ Ward, JA O'Brien - FREE Full Text
Cited by 6 - Related articles

[PDF] Combination therapy for type 2 diabetes: what are the potential health and cost implications …


JJ Caro, M Salas, AJ Ward, G Raggio, JA O' … - Canadian Journal of Diabetes, 2003 - diabetes.ca
With monotherapy, the average costs of managing complica- tions that accumulate
over the mean survival of 13.7 years are Can $24 450 per patient, and metformin
treatment adds $9710. Combination therapy reduces the costs of complica- ...
Cited by 1 - Related articles - View as HTML - All 3 versions

The direct medical cost of type 2 diabetes

- diabetesjournals.org
M Brandle, H Zhou, BRK Smith, D Marriott, … - Diabetes Care, 2003 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—We studied a random sample of 1,364 subjects with
type 2 diabetes who were members of a Michigan health maintenance organization.
Demographic characteristics, duration of diabetes, diabetes treatments, ...
Cited by 122 - Related articles - BL Direct - All 6 versions

The impact of cardiovascular disease on medical care costs in subjects with and without …


GA Nichols, JB Brown - Diabetes Care, 2002 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—We compared the prevalence of CVD and medical care
costs for subjects with and without CVD in all 16,180 full-year health
maintenance organization members in 1999 who had been diagnosed with type 2 ...
Cited by 42 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google